摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

胞苷酰-(3',5')-鸟苷 | 2382-65-2

中文名称
胞苷酰-(3',5')-鸟苷
中文别名
可控孔径玻璃
英文名称
[5']guanylic acid cytidin-3'-yl ester
英文别名
5'-C-G-3';cytidylyl-(3'->5')-guanosine;[5']Guanylsaeure-cytidin-3'-ylester;Cytidylyl-(3',5')-guanosine;[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate
胞苷酰-(3',5')-鸟苷化学式
CAS
2382-65-2
化学式
C19H25N8O12P
mdl
——
分子量
588.428
InChiKey
CTMZLDSMFCVUNX-VMIOUTBZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    0.4 g/mL at 20 °C (lit.)

计算性质

  • 辛醇/水分配系数(LogP):
    -5.7
  • 重原子数:
    40
  • 可旋转键数:
    8
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    299
  • 氢给体数:
    8
  • 氢受体数:
    14

安全信息

  • 安全说明:
    S26,S36
  • 危险类别码:
    R36/37/38

SDS

SDS:782c6246a5fc30431d05f169036fd44f
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Kinetic Analysis of the Cleavage of the Ribose Phosphodiester Bond within Guanine and Cytosine-Rich Oligonucleotides and Dinucleotides at 65–200 °C and Its Implications Concerning the Chemical Evolution of RNA
    摘要:
    一种快速热水解反应的监测方法成功应用于对寡核苷酸和二核苷酸中肋糖磷酸二酯键断裂的动力学分析,研究温度为150-200 °C。确定了在寡核苷酸和二核苷酸中肋糖3′,5′-细胞苷酸-鸟苷酸序列(-C3′pGd-)的降解表观速率常数(kapp),结果表明在寡核苷酸中,-C3′pGd-序列的稳定性低于2′,5′-细胞苷酸-鸟苷酸(C2′pG)和3′,5′-细胞苷酸-鸟苷酸(C3′pG)。令人意外的是,目标序列的稳定性依赖于寡核苷酸的周围序列,尽管研究中使用的温度远高于熔点。2′-脱氧细胞苷酸-2′-脱氧鸟苷酸(CdpGd)的磷酸二酯键在低温下的稳定性远高于肋糖磷酸二酯键,但在200 °C时变得相当。C2′pG或C3′pG降解过程中观察到C2′pG与C3′pG之间的相互转化以及磷酸二酯键的断裂。基于对相互转化程度的分析,C2′pG和C3′pG消失的表观速率常数被分解为水解速率常数(khy)和相互转化速率常数(kint),其中khy的值大于kint。目标序列降解的表观活化能为寡核苷酸100-109 kJ mol−1,C3′pG为90 kJ mol−1,C2′pG为87 kJ mol−1,以及CdpGd为139 kJ mol−1。还确定了目标序列降解的表观活化焓和熵变;五种寡核苷酸的活化参数值为ΔH≠app = 94-105 kJ mol−1和ΔS≠app = −(36-59) J mol−1 T−1,C3′pG为ΔH≠app = 86 kJ mol−1和ΔS≠app = −97 J mol−1 T−1,C2′pG为ΔH≠app = 84 kJ mol−1,ΔS≠app = −105 J mol−1 T−1,CdpGd为ΔH≠app = 135 kJ mol−1,ΔS≠app = +2 J mol−1 T−1。寡核苷酸的活化参数ΔH≠app和ΔS≠app随-C3′pGd-周围序列的长度增加而增加;这一事实清楚地表明,周围序列对目标肋糖磷酸二酯键的稳定性存在影响。基于动力学分析,讨论了高温下肋糖磷酸二酯键降解的反应机制。此外,从生命的水热起源的角度讨论了RNA化学演化的可能途径。
    DOI:
    10.1246/bcsj.76.153
  • 作为产物:
    参考文献:
    名称:
    1' #,2',3',4' #,5',5” -2 H 6 -β-D-核糖核苷和1' #,2',2”,3',4' #,5的合成',5″ -2 H 7 -β-D-2'-脱氧核糖核苷用于选择性抑制部分氘化的oligo-DNA,oligo-RNA和2,5A核中的质子共振(1 H-NMR窗口)
    摘要:
    阮内镍-2 H 2 O在甲基α/β-D-呋喃核糖苷[α/β= 〜3:10] 1的差向异构体混合物上的交换反应产生了甲基1 #,2,3,4 #,5,5'- 2 H 6 -α/β-呋喃核糖苷2 [在C2,C3,C5 / 5'处为97原子%2 H;C 4(C4 #)〜85原子%2 H ;在C1(C1 #)]处约20个原子%2 H,以60 – 80%的产率获得,同时还得到了差向异构的木糖和阿拉伯糖副产物。在干燥的吡啶中将粗产物2甲苯磺酸化,并在硅胶柱上小心分离,得到纯的1-O-甲基-2,3,5-三-O-(4-甲苯甲酰基)-α/β-D-1#,2,3,4 #,5,5'- 2 H 6-核呋喃糖苷4(48%)。4转化为1-O-乙酰基-2,3,5-三-O-甲苯甲酰基-α/β-D-1 #,2,3,4 #,5,5'- 2 H 6-核呋喃糖苷6( 82%的人提供了合成氘核糖核苷用于RNA或DNA合成的关键组成部分。然后将化合物6与甲硅烷基尿嘧啶,N
    DOI:
    10.1016/s0040-4020(01)82001-9
  • 作为试剂:
    描述:
    (7-chlorocyclohept-2-en-1-yl)-trimethylsilane 在 胞苷酰-(3',5')-鸟苷 作用下, 生成 1,3-环庚二烯
    参考文献:
    名称:
    Les(triméthylsilyl)bicyclo [ n .1.0]-炔烃,nouveaux silylcyclopropanes bicycliques fonctionnels †
    摘要:
    双环[n.1.0]-硅酮合成的原理和方法,从简单到快速。Elle permet d'accéderdans de bonnes条件是aus deuxisomèresendo et exomonosiliciésainsi qu'aux类似物gem- disiliciés。
    DOI:
    10.1002/recl.19881070322
点击查看最新优质反应信息

文献信息

  • Catalysis of Diribonucleoside Monophosphate Cleavage by Water Soluble Copper(II) Complexes of Calix[4]arene Based Nitrogen Ligands
    作者:Roberta Cacciapaglia、Alessandro Casnati、Luigi Mandolini、David N. Reinhoudt、Riccardo Salvio、Andrea Sartori、Rocco Ungaro
    DOI:10.1021/ja0632106
    日期:2006.9.1
    Calix[4]arenes functionalized at the 1,2-, 1,3-, and 1,2,3-positions of the upper rim with [12]ane-N-3 ligating units were synthesized, and their bi-and trimetallic zinc(II) and copper( II) complexes were investigated as catalysts in the cleavage of phosphodiesters as RNA models. The results of comparative kinetic studies using monometallic controls indicate that the subunits of all of the zinc(II) complexes and of the 1,3-distal bimetallic copper(II) complex 7-Cu-2 act as essentially independent monometallic catalysts. The lack of cooperation between metal ions in the above complexes is in marked contrast with the behavior of the 1,2-vicinal bimetallic copper(II) complex 6-Cu-2, which exhibits high catalytic efficiency and high levels of cooperation between metal ions in the cleavage of HPNP and of diribonucleoside monophosphates NpN'. A third ligated metal ion at the upper rim does not enhance the catalytic efficiency, which excludes the simultaneous cooperation in the catalysis of the three metal ions in 8-Cu-3. Rate accelerations relative to the background brought about by 6-Cu-2 and 8-Cu-3 (1.0 mM catalyst, water solution, pH 7.0, 50 degrees C) are on the order of 10(4)-fold, largely independent of the nucleobase structure, with the exception of the cleavage of diribonucleoside monophosphates in which the nucleobase N is uracil, namely UpU and UpG, for which rate enhancements rise to 10(5)-fold. The rationale for the observed selectivity is discussed in terms of deprotonation of the uracil moiety under the reaction conditions and complexation of the resulting anion with one of the copper(II) centers.
  • The p<i>K</i><sub>a</sub> of the Internucleotidic 2‘-Hydroxyl Group in Diribonucleoside (3‘→5‘) Monophosphates
    作者:S. Acharya、A. Földesi、J. Chattopadhyaya
    DOI:10.1021/jo026545o
    日期:2003.3.1
    Ionization of the internucleotidic 2'-hydroxyl group in RNA facilitates transesterification reactions in Group I and II introns (splicing), hammerhead and hairpin ribozymes, self-cleavage in lariat-RNA, and leadzymes and tRNA processing by RNase P RNA, as well as in some RNA cleavage reactions promoted by ribonucleases. Earlier, the pK(a) of 2'-OH in mono- and diribonucleoside (3'-->5') monophosphates had been measured under various nonuniform conditions, which make their comparison difficult. This work overcomes this limitation by measuring the pK(a) values for internucleotidic 2'-OH of eight different diribonucleoside (3'-5') monophosphates under a set of uniform noninvasive conditions by H-1 NMR. Thus the pK(a) is 12.31 (+/-0.02) for ApG and 12.41 (+/-0.04) for ApA, 12.73 (+/-0.04) for GpG and 12.71 (+/-0.08) for GpA, 12.77 (+/-0.03) for CpG and 12.88 (+/-0.02) for CpA, and 12.76 (+/-0.03) for UpG and 12.70 (+/-0.03) for UpA. By comparing the pK(a)s of the respective 2'-OH of monomeric nucleoside 3'-ethyl phosphates with that of internucleotidic 2'-OH in corresponding diribonucleoside (3'-5') monophosphates, it has been confirmed that the aglycons have no significant effect on the pKa values of their 2'-OH under our measurement condition, except for the internucleotidic 2'-OH of 9-adeninyl nucleotide at the 5'-end (ApA and ApG), which is more acidic by 0.3-0.4 pK(a) units.
  • Dimroth; Witzel, Justus Liebigs Annalen der Chemie, 1959, vol. 620, p. 109,110,116,118
    作者:Dimroth、Witzel
    DOI:——
    日期:——
  • KOMIYAMA, MAKOTO, CARBOHYDR. RES., 192,(1989) C. 97-102
    作者:KOMIYAMA, MAKOTO
    DOI:——
    日期:——
  • DEUTERATED NUCLEOSIDES
    申请人:CHATTOPADHYAYA, Jyoti
    公开号:EP0648220A1
    公开(公告)日:1995-04-19
查看更多

同类化合物

鸟苷酰-(3'-5')-尿苷 鸟苷酰(3'-5')尿苷3'-单磷酸酯 腺苷酰基-(3,’5’)-胞苷 腺苷酰-(3'→5')-胞苷 腺苷酰-(3'-5')-尿苷3'-单磷酸酯 腺苷基3'-5'-腺苷铵盐 脱氧鸟苷酰-(3'-5')-脱氧腺苷 脱氧腺苷酰-(3'-5')-脱氧鸟苷 脱氧胞苷酰-(3'-5')-脱氧鸟苷 胸苷酰(3'->5')胸苷铵盐 胸苷基(3'5')-2'-脱氧腺苷铵盐 胞苷酰-(5'->3')-鸟苷 胞苷酰-(3',5')-鸟苷 胞苷酰(3'->5')尿苷铵盐 聚(2-氨基脱氧腺嘌呤基-5-碘脱氧尿苷酸) 聚(2-氨基脱氧腺嘌呤基-5-溴脱氧尿苷酸) 环二腺苷酸 尿酸氧化酶 尿苷酰基-(3',5')-尿苷 二(3',5')-环二鸟苷酸 乙基3,4,5-三[[(6-重氮基-5,6-二氢-5-羰基-1-萘基)磺基基]氧代]苯酸酯 [5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基][5-(2,4-二氧代嘧啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [5-(6-氨基嘌呤-9-基)-3,4-二羟基-四氢呋喃-2-基]甲基[羟基-[2,3,4-三羟基-5-(7-甲基-2,4,8-三氧代-1H-嘧啶并[4,5-b]喹啉-10-基)戊氧基]磷酰]磷酸氢酯 [5-(4-氨基-2-氧代-嘧啶-1-基)-3,4-二羟基-四氢呋喃-2-基]甲基[5-(4-氨基-2-氧代-嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(6-氨基嘌呤-9-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,5R)-5-(2,4-二氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基 [(2R,3S,5R)-2-(羟基甲基)-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2,4-二氧代嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 8-氯-黄素腺嘌呤二核苷酸 8-巯基-黄素腺嘌呤二核苷酸 5'-O-胸苷酰 3'-O-(2'-脱氧腺苷)硫代磷酸酯 2'-脱氧鸟苷酰-(5'-3')-2'-脱氧-5'-鸟苷酸 2'-脱氧鸟苷酰-(3'-5')-2'-脱氧胞苷 2'-脱氧腺苷酰-(3'-5')-2'-脱氧腺苷 2'-脱氧胞啶基(3'->5')-2'-脱氧鸟苷铵盐 1-(2-脱氧-5-O-磷羧基五呋喃糖基)-5-[(1E)-3-{[5-(2-羰基六氢-1H-噻吩并[3,4-d]咪唑-4-基)戊酰基]氨基}丙-1-烯-1-基]嘧啶-2,4(1H,3H)-二酮 5'-dCT 2'-deoxyadenylyl-(3',5')-thymidine ammonium salt d(GpT) [(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-yl] [(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-prop-2-ynoxyoxolan-2-yl]methyl hydrogen phosphate pA3'p5'U pG3'p5'U pG3'p5'C cytidylyl-(3'-5')-3'-amino-3'-deoxy-3'-L-phenylalanyl-N6,N6-dimethyladenosine adenylyl-(3',5')-guanosine deoxyadenosyl(5'-3')thymidine phosphate cAIMP N4-palmitoyl-2'-deoxycytidylyl-(3'->5')-5-fluoro-2'-deoxyuridine